Cytoki Pharma
Denmark - SøborgPharmaceutical
Focus: Cytoki Pharma is a Danish immunology-focused biotech founded in 2019 that develops medicines targeting IL-22 biology. The company is in early-stage clinical development with a lean, pre-revenue model.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Cytoki Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Cytoki Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CK-0045
HealthyClinical Trials (1)
NCT05712876A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity
Phase 1Help build intelligence for Cytoki Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.